The Dow has technically entered a bull market after Jerome Powell's comments yesterday Still, those that want to play the rebound should keep in mind that macro risks remain Here...
Many growth stocks and exchange-traded funds (ETFs) are currently changing hands around 52-week or even multi-year lows and the impending earnings season could bring more...
The US Federal Reserve has recently delivered its most significant interest rate hike since 1994 to counter four-decade high inflation, pushing the S&P 500 deeper into bear market...
Biotechnology stocks represent companies that research, develop or market healthcare-related therapies or products. They typically use living organisms, biological systems, or...
AbbVie (NYSE:ABBV) has recently suffered a sell-off, triggered by the Aug. 31 FDA announcement that the packaging of Rinvoq, its prescription drug for rheumatoid arthritis, will...
"The global health industry was worth $8.45 trillion in 2018 and global healthcare could reach over $10 trillion by 2022," according to PolicyAdvice a US insurance specialist. And...
The increase in global cases of the Delta variant has meant increased volatility for many stocks. Yet, broader indices keep making new highs. So far in the year, the Dow Jones...
Healthcare, especially vaccine development and rollout efforts, has become one of the most widely-followed topics during the pandemic. And due to the pandemic, a large number of...
If you’re building an investment portfolio for your golden years, it makes sense to buy some quality dividend-paying stocks that offer predictable income as well as long-term...
Wall Street's fourth quarter earnings season kicks off this week, with JPMorgan Chase (NYSE:JPM), Citigroup (NYSE:C), and Wells Fargo (NYSE:WFC) all set to report their latest...